Welcome to LookChem.com Sign In|Join Free

CAS

  • or

7303-50-6

Post Buying Request

7303-50-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • SAGECHEM/2-Amino-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)propanoic acid/SAGECHEM/Manufacturer in China

    Cas No: 7303-50-6

  • No Data

  • No Data

  • No Data

  • SAGECHEM LIMITED
  • Contact Supplier

7303-50-6 Usage

Chemical Properties

White Powder

Uses

DL-7-Azatryptophan is an unusual alpha-amino acid with a very potent fluorescent activity. Its used as a vehicle for probing the structure and dynamics of protein and peptides

Check Digit Verification of cas no

The CAS Registry Mumber 7303-50-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,3,0 and 3 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 7303-50:
(6*7)+(5*3)+(4*0)+(3*3)+(2*5)+(1*0)=76
76 % 10 = 6
So 7303-50-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H11N3O2/c11-8(10(14)15)4-6-5-13-9-7(6)2-1-3-12-9/h1-3,5,8H,4,11H2,(H,12,13)(H,14,15)

7303-50-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name DL-7-Azatryptophan Monohydrate

1.2 Other means of identification

Product number -
Other names 7-AZATRYPTOPHAN

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7303-50-6 SDS

7303-50-6Relevant articles and documents

MACROCYCLIC INHIBITORS OF THE PD-1/PD-L1 AND CD80 (B7-1)/PD-LI PROTEIN/PROTEIN INTERACTIONS

-

, (2016/05/24)

The present disclosure provides novel macrocyclic peptides which inhibit the PD-1/PD-L1 and PD-L1/CD80 protein/protein interaction, and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7303-50-6